Indian drug companies start off a price war on experimental Covid-19 drugOver the next few weeks, close to 10 drug companies including Abbott, Lupin, Micro Labs, Mcleods Pharma, Cipla, Strides Pharma and Dr Reddy...
25 Jul, 2020, 07.49 AM IST
Trending stocks: Dr. Reddy's Laboratories shares up nearly 1%A total of 9,119 shares changed hands on the counter till 11:07AM (IST).
02 Jul, 2020, 11.09 AM IST
Dr Reddy’s partners Fujifilm to launch Avigan for Covid-19 treatmentThe agreement provides for Fujifilm Toyama Chemical, a unit of the Japanese company to grant Dr. Reddy's and Dubai-based Global Response Ai...
01 Jul, 2020, 04.32 PM IST
Local Covid drug makers ramp up capacityThis follows companies successfully developing the formulations Favipiravir and Remdesivir, the drugs, which along with dexamethasone have ...
23 Jun, 2020, 09.17 PM IST
Glenmark Pharma to study potential Covid-19 drug combinationThe study will look to enroll 158 hospitalized patients of moderate Covid-19 in India, the company added. Last month, Glenmark said it woul...
26 May, 2020, 04.19 PM IST
Strides Pharma to conduct trials in India for potential COVID-19 drugThe Bengaluru-based company has received approval from the Drug Controller General of India to conduct trials of favipiravir in the country...
21 May, 2020, 10.44 AM IST
Trending stocks: Hikal shares jump 5% on development of Favipiravir APIA total of 32,209 shares changed hands on the counter till 11:40AM (IST).
15 May, 2020, 11.45 AM IST
Glenmark pharma starts clinical trial on antiviral Favipiravir for Covid-19 treatmentThe drug sold under brand name Avigan by Fujifilm Toyama Chemical has demonstrated activity against influenza viruses and has been approved...
30 Apr, 2020, 03.10 PM IST
Biocon's partner firm launches diabetes product in JapanIn March this year, Biocon received approval from the Japanese health authority to sell its biosimilar product Insulin Glargine.
15 Jul, 2016, 12.52 PM IST
Sun Pharma’s Novartis deal could be a bright spotSun Pharma’s acquisition of 14 established prescription brands of Swiss drug maker Novartis in Japan will give it a headstart in the $73 bi...
01 Apr, 2016, 09.15 AM IST
Approval for insulin biosimilar in Japan a milestone for Biocon: Kiran Mazumdar Shaw, BioconThis will also help Biocon enter the US and European markets in the near future
29 Mar, 2016, 08.28 AM IST
Natco takes a beating on FDA observation“The company believes there would be no adverse impact to its current or future pipeline products coming from these facilities,” Natco Phar...
29 Mar, 2016, 03.09 AM IST
Biocon gets nod to sell its diabetes product 'Insulin Glargine' in JapanBiocon has received approval from the Japanese health authority to sell its biosimilar product 'Insulin Glargine' in that country.
28 Mar, 2016, 04.08 PM IST
Fujifilm, Dr Reddy’s call off Japanese JV pactDr. Reddy's Laboratories and Japan's Fujifilm Corp have decided to terminate joint venture partnership they entered into in July 2011.
03 Jun, 2013, 04.10 PM IST
Dr Reddy’s calls off joint venture with Fujifilm; stock upThe two companies had conducted detailed studies on the establishment of a joint venture for developing and manufacturing generic drugs.
03 Jun, 2013, 03.09 PM IST
- Piramal Healthcare signs pact with Japan's Fujifilm Diosynth
Mumbai-based Piramal Healthcare has teamed up with Japan's Fujifilm Diosynth for a contract manufacturing deal that would look to develop a...
30 Oct, 2012, 06.00 AM IST
- Dr Reddy's Laboratories may seal pact with Fujifilm for Japanese JV by June
Dr Reddy's Laboratories expects to sign a definitive agreement by June with Japan-based Fujifilm for a joint venture that will develop and ...
27 Mar, 2012, 05.24 PM IST